Monopoly: The Structural Verdict
A federal antitrust settlement confirms the peril of structural market dominance.
The Context
On 5 March 2026, the trial of United States v. Live Nation Entertainment was halted. A settlement was reached one week after proceedings began, following the introduction of damning internal communications. The core claim, preserved in a summary judgment ruling on 18 February 2026, was illegal monopolisation across three vertically integrated markets. Live Nation controlled approximately 78 percent of major amphitheaters, wielding “outsized leverage.” The settlement mandates the divestiture of 13 amphitheaters, imposes a 15 percent fee cap on service charges, and forces the opening of its platform to competitors. A separate federal class action, certified in December 2025, seeks 15 years of damages on over 400 million tickets.
The Risk
This is not merely a corporate fine. It is a structural remedy—a court-ordered breakup. For a director, this represents a catastrophic failure of governance oversight. Under the Companies Act 1993, directors have a duty to act in good faith and in the best interests of the company. Knowingly presiding over, or failing to challenge, a business model that constitutes an illegal monopoly may indicate a breach of that duty. The liability hook is twofold: the direct financial exposure from the $280 million settlement and the class action, and the existential risk of forced divestiture. The precedent is clear. The state will pursue structural separation where dominance is proven. Directors may be personally liable if found to have permitted or encouraged conduct that violates competition law, exposing the company to such severe penalties.
The Control
Governance must shift from revenue protection to structural compliance. The board must mandate an independent, external audit of all exclusive contracts and market share data in any New Zealand operations. This audit must be framed against the Commerce Act 1986, New Zealand’s primary antitrust legislation. The terms of reference must explicitly assess the risk of a ‘substantial lessening of competition.’ All long-term exclusivity agreements must be reviewed for enforceability and strategic risk. The legal team must be directed to provide regular, written briefings on global antitrust enforcement trends, treating them as material enterprise risks.
The Challenge
These are the critical questions you should be raising at the board table:
| What is our current market share in each vertical of our core business, and at what threshold does our legal counsel advise it becomes a material competition law risk under the Commerce Act? | |
| Can management produce all internal communications and policies regarding competitor access or pricing, and are we confident they would withstand a regulator’s forensic examination? | |
| What is our concrete, board-approved plan to voluntarily restructure or divest assets to pre-empt a regulatory action that could force a breakup, and what is the financial modelling for that scenario? |